Bulletin Archive
This archived information is dated to the 2008-09 academic year only and may no longer be current.
For currently applicable policies and information, see the current Stanford Bulletin.
This archived information is dated to the 2008-09 academic year only and may no longer be current.
For currently applicable policies and information, see the current Stanford Bulletin.
Emeriti: Malcolm A. Bagshaw, Peter Fessenden, Don R. Goffinet, George M. Hahn, Kendric Smith
Chair: Richard T. Hoppe
Professors: J. Martin Brown, Sarah S. Donaldson, Amato J. Giaccia, Steven L. Hancock, Richard T. Hoppe, Quynh-Thu Le, Daniel S. Kapp, Steven A. Liebel
Associate Professors: Iris C. Gibbs, Paul Keall, Christopher R. King, Susan J. Knox, Gary Luxton, Lei Xing
Assistant Professors: Laura Attardi, Daniel Chang, Nicholas Denko, Edward Graves, Albert C. Koong
Consulting Professor: Robert M. Sutherland
Courses offered by the Department of Radiation Oncology have the subject code RADO, and are listed in the "Radiation Oncology [RADO] Courses" section of this bulletin.
Radiation Oncology focuses on the use of radiation for cancer therapy and research. The department does not offer degrees; however, its faculty teach courses open to medical students, graduate students, and undergraduates. The department also accepts students in other curricula as advisees for study and research. Graduate students in Biophysics and Cancer Biology may perform their thesis research in the department. Undergraduates may arrange individual research projects under supervision of faculty.
At the present time, the major areas of basic research investigation in the department include: DNA repair in mammalian cells after ionizing irradiation; studies of the mechanism of tumor hypoxia in animal tumors; development of new anti-cancer drugs to exploit tumor hypoxia; cytogenetic and molecular methods of predicting the sensitivity of individual tumors to cancer therapy; radiolabeled monoclonal antibodies for cancer detection and treatment; studies of oxygen levels in human tumors using polarographic electrodes; clinical trials of a new hypoxic cytotoxic agent (tirapazamine); studies of the late effects of cancer therapy; and techniques of conformal and intensity modulated radiation therapy.
© Stanford University - Office of the Registrar. Archive of the Stanford Bulletin 2008-09. Terms of Use | Copyright Complaints